The overarching goal of the Meharry RCTR (MeTRC) is to expand and strengthen the overall research infrastructure at Meharry Medical College (MMC) for conducting and promoting clinical and translational research (CTR) in health disparities, with a major emphasis to reduce or eliminate disease burden in minorities regarding inflammatory diseases, HIV/AIDS, diabetes/obesity, cancer and neurological diseases. We will achieve this by (1) providing effective and highly dynamic leadership to expand and promote the infrastructure to support innovative CTR discoveries which address the science of health disparities;(2) foster sustained, productive intra- and inter-institutional collaborations that san the translational research spectrum and will include basic, social and behavioral scientists, clinical researchers and community-based researchers;(3) expand and strengthen professional development to foster mentorship and promotion of investigators towards successful establishment of competitive and externally funded CTR projects;(4) develop and implement a plan for self-evaluation of short- and long-term RCTR goals including implementation and tracking of program activities;(5) expand CTR capacity by recruiting additional clinician-scientists and community-based-participatory research (CBPR) investigators;(6) enhance CTR enterprise by further developing our research infrastructure, including developing data warehouses, management and integration of hardware and software systems;(7) enhance research design, biostatistical analysis and clinical research ethics and related research training opportunities;(8) enhance the infrastructure to improve minority participation in CTR by providing an environment that fosters patient interactions involving intra- and inter-institutional collaborations;(9) expand and promote the community engagement in innovative CTR that increases the capacity of investigators to efficiently conduct qualitative CBPR, as well as expand the use of communication strategies that are sensitive to literacy, cultural differences and psychosocial factors;(10) enhance research support services to assist investigators in navigating the complex regulatory environment surrounding the conduct of CTR, while fostering and maintaining a "culture of compliance";(11) enhance technical and support infrastructure to accelerate research discovery in clinical and translational sciences such as proteomics, genomics, cell and tissue imaging, advanced data analysis and other data intensive research areas;(12) build upon our previous T1 research success support of highly competitive interdisciplinary collaborative pilot project research clusters/program that promote health disparity research along the T2-T4 translational research trajectory.

Public Health Relevance

The Meharry Clinical Translational Research Center (MeTRC) will provide an environment for conducting and promoting clinical and translational research in health disparities that seek to reduce or eliminate disease burden in minorities. Research will focus primarily on inflammatory/infectious diseases, diabetes, cardiovascular diseases, cancer and neurological disorders that affect the populations we serve.

Agency
National Institute of Health (NIH)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54MD007593-06
Application #
8807088
Study Section
Special Emphasis Panel (ZMD1)
Program Officer
Mcclure, Shelia A
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Meharry Medical College
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Nashville
State
TN
Country
United States
Zip Code
37208
Hoekstra, William J; Hargrove, Tatiana Y; Wawrzak, Zdzislaw et al. (2016) Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi. Antimicrob Agents Chemother 60:1058-66
Laknaur, Archana; Foster, Terri-Lee; Bobb, Lesley E et al. (2016) Altered expression of histone deacetylases, inflammatory cytokines and contractile-associated factors in uterine myometrium of Long Evans rats gestationally exposed to benzo[a]pyrene. J Appl Toxicol 36:827-35
Matthews, Qiana L; Farrow, Anitra L; Rachakonda, Girish et al. (2016) Epitope Capsid-Incorporation: New Effective Approach for Vaccine Development for Chagas Disease. Pathog Immun 1:214-233
Udoko, Aniekanabassi N; Johnson, Candice A; Dykan, Andrey et al. (2016) Early Regulation of Profibrotic Genes in Primary Human Cardiac Myocytes by Trypanosoma cruzi. PLoS Negl Trop Dis 10:e0003747
Borza, Dorin-Bogdan (2016) Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation. Matrix Biol :
Pulliam, Stephanie R; Uzhachenko, Roman V; Adunyah, Samuel E et al. (2016) Common gamma chain cytokines in combinatorial immune strategies against cancer. Immunol Lett 169:61-72
Banks, Leah D; Amoah, Priscilla; Niaz, Mohammad S et al. (2016) Olive oil prevents benzo(a)pyrene [B(a)P]-induced colon carcinogenesis through altered B(a)P metabolism and decreased oxidative damage in Apc(Min) mouse model. J Nutr Biochem 28:37-50
Ho, Meng-Hsuan; Huang, Li; Goodwin, J Shawn et al. (2016) Two Small Molecules Block Oral Epithelial Cell Invasion by Porphyromons gingivalis. PLoS One 11:e0149618
Stewart, Cassandra R; Obi, Nneka; Epane, Elodie C et al. (2016) Effects of Diabetes on Salivary Gland Protein Expression of Tetrahydrobiopterin and Nitric Oxide Synthesis and Function. J Periodontol 87:735-41
Harris, Kelly L; Pulliam, Stephanie R; Okoro, Emmanuel et al. (2016) Western diet enhances benzo(a)pyrene-induced colon tumorigenesis in a polyposis in rat coli (PIRC) rat model of colon cancer. Oncotarget 7:28947-60

Showing the most recent 10 out of 119 publications